RE: Message for Agent B3 Feb 2021 16:02
Hi Albus, NCYT has certainly had a great run during Covid, but PCR was never intended for the diagnostic purposes that it has been used for and, increasingly, its ‘gold standard’ position is being questioned due to high false positives Even worse for NYCT, all the testing competitors are closing in on them with more innovative solutions and they increasingly appear as a one-trick pony/busted flush. Hence the SP is not looking too pretty since they published results.
I am sure that many life science companies will be eyeing up Paraytec’s test, the question is how easily they can get it from BRH for a decent price?